Local view for "http://purl.org/linkedpolitics/eu/plenary/2005-12-13-Speech-2-360"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20051213.60.2-360"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
".
I am standing in for Mr Verheugen on this issue, but I know something about this because of my previous responsibilities in this field.
The problem of a black market in medicinal products is very closely related to counterfeiting activities. Counterfeit medicinal products, inside and outside the Union, are a subject of ongoing concern in the EU, the Council of Europe and the World Health Organisation. Part of the overall problem is that, recently, antiviral drugs have potentially been at risk in counterfeiting activities. The possibility that such drugs could be in short supply has become a concern for many people. The situation is naturally attractive to counterfeiters.
Over recent years, the Commission has taken action to address this problem at a horizontal level, as regards intellectual property and customs actions. The legal framework has been changed, and indeed several times, in order to improve the enforcement of intellectual property rights and customs action.
In September this year the Council of Europe published a survey report that provides an update on the extent of counterfeiting in the pharmaceutical sector. It is currently evaluating the possibility of further action based on that report. At the same time, the WHO has proposed a framework convention to combat counterfeit medicinal products at global level.
The Member States are responsible for the enforcement of any activities against counterfeiters. Therefore, the Member States are currently evaluating the results of a survey with the aim of identifying the extent of the problem of counterfeit medicines and the development of an anti-counterfeit strategy.
While the above-mentioned actions of the Commission and the Member States are far reaching, the Commission continuously monitors and analyses the situation for possible legal implications within the European Union and opportunities for future international cooperation."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples